Biotech Blogs and Articles
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests
NewsDealsSocialBlogsVideosPodcasts
BiotechBlogsPhenotypic Age Predicts Mortality Risk in Parkinson's Disease Patients
Phenotypic Age Predicts Mortality Risk in Parkinson's Disease Patients
BioTech

Phenotypic Age Predicts Mortality Risk in Parkinson's Disease Patients

•February 3, 2026
Fight Aging!
Fight Aging!•Feb 3, 2026
0

Summary

The post discusses a new study using the Phenotypic Age (PhenoAge) clock to predict mortality risk in Parkinson's disease (PD) patients, finding that higher PhenoAge and its acceleration are strong independent predictors of death alongside factors like age, male sex, smoking, underweight, depression, LDL levels, and genetics. By analyzing 569 UK Biobank PD cases with Cox regression and a nomogram, the researchers demonstrate that PhenoAge can reliably stratify patients for targeted interventions. The author emphasizes that, while aging clocks still lack full mechanistic validation, accumulating outcome data—such as this mortality link—is the most practical way to assess their utility.

Phenotypic Age Predicts Mortality Risk in Parkinson's Disease Patients

Read Original Article

Comments

Want to join the conversation?